Celera Diagnostics Announces Target & Marker Discovery Collaboration With Merck
Research to Focus Primarily on Alzheimer's Disease
29-Jul-2004 -
Celera Diagnostics, a joint venture between the Celera Genomics Group and Applied Biosystems Group of Applera Corporation, today announced it has entered into a collaboration with Merck & Co., Inc. to identify novel targets for drug discovery and diagnostic markers related to Alzheimer's ...
Alzheimer's disease
Applera
Applied Biosystems
+13